AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

4,911.00p
   
  • Change Today:
      30.00p
  • 52 Week High: 5,508.00
  • 52 Week Low: 4,194.00
  • Currency: UK Pounds
  • Shares Issued: 1,265.98m
  • Volume: 746,495
  • Market Cap: 62,172m
  • RiskGrade: 96

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 4.3% 4.4%
Div Cover 1.5 1.4
Op Mrgn 23.0% 25.9%
ROCE n/a  
Latest F'cast
P/E 15.1 16.9
PEG 12.8 n/a
Pr/Revenue 3.9 3.7
Pr/Book 4.9  
Latest F'cast
Revenue -9.8% -41.4%
PBT 15.7% -9.1%
EPS 1.2% -11.1%
DPS n/a -43.3%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 27,973.00 7,646.00 683.00¢ 5.7 n/a -6% 280.00¢ 7.2%
31-Dec-13 25,711.00 3,267.00 505.00¢ 9.5 n/a -26% 280.00¢ 5.8%
31-Dec-14 26,095.00 1,246.00 428.00¢ 14.3 n/a -15% 280.00¢ 4.6%
31-Dec-15 23,641.00 3,069.00 426.00¢ 14.5 n/a -0% 280.00¢ 4.5%
31-Dec-16 21,319.00 3,552.00 431.00¢ 13.8 13.8 +1% 280.00¢ 4.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 16,729.00 4,327.06 287.91p 17.0 n/a -11% 212.88p 4.4%
31-Dec-18 16,837.00 4,135.33 274.93p 17.8 n/a -4% 214.64p 4.4%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

FDA accepts Tagrisso submission for 1st-line nsclc 18-Dec-2017 07:00 RNS
Director/PDMR Shareholding 15-Dec-2017 12:00 RNS
Total Voting Rights 01-Dec-2017 15:00 RNS

Latest AstraZeneca Director Deals

Traded Action Notifier PriceAmountValue
13-Dec-17 Transfer To Pascal Soriot 0.000p 40,148 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 4,911.00p
Change Today 30.00p
% Change 0.61 %
52 Week High 5,508.00
52 Week Low 4,194.00
Volume 746,495
Shares Issued 1,265.98m
Market Cap 62,172m
RiskGrade 96

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.92% below the market average53.92% below the market average53.92% below the market average53.92% below the market average53.92% below the market average
19.35% above the sector average19.35% above the sector average19.35% above the sector average19.35% above the sector average19.35% above the sector average
Price Trend
0.71% above the market average0.71% above the market average0.71% above the market average0.71% above the market average0.71% above the market average
16.92% above the sector average16.92% above the sector average16.92% above the sector average16.92% above the sector average16.92% above the sector average
Income
69.98% above the market average69.98% above the market average69.98% above the market average69.98% above the market average69.98% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Growth
50.38% below the market average50.38% below the market average50.38% below the market average50.38% below the market average50.38% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average

What The Brokers Say

Strong Buy 20
Buy 2
Neutral 11
Sell 1
Strong Sell 4
Total 38
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 10-Aug-17 16-Feb-17
Paid 11-Sep-17 20-Mar-17
Amount 90.00¢ 190.00¢

Trades for 18-Dec-2017

Time Volume / Share Price
16:29 212 @ 4,911.00p
16:29 17 @ 4,911.00p
16:29 83 @ 4,911.00p
16:29 3 @ 4,911.00p
16:29 52 @ 4,911.00p

Top of Page